News

Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), and Antheia, the pharmaceutical ingredient manufacturer transforming essential medicine ...
Richmond, Virginia, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Phlow Corp., a U.S.-based public benefit corporation leveraging advanced manufacturing processes to re-imagine the domestic production of ...
Phlow Announces Close of $37M Series C Financing to Accelerate Modern Medicine Development and Manufacturing in America Provided by GlobeNewswire Jul 22, 2025, 6:12:13 AM ...
“Phlow has embarked on a bold mission to provide access to affordable, high-quality essential medicines for every American,” said Eric Edwards, M.D., Ph.D., co-founder, president and CEO of Phlow.
Richmond pharmaceutical manufacturing company Phlow announced Tuesday that it had raised $37 million in a Series C funding round led by Align Private Capital. The funding round, which was also ...
Phlow Corp. CEO Eric Edwards (left) co-founded the Richmond-based pharmaceutical company with Virginia Commonwealth University professor Frank Gupton.
Phlow provides a solution to the broken essential medicines supply chain by offering a resilient end-to-end solution that is U.S.-based, comprehensive, and fully integrated.
From the Winter 2021/2022 issue of Inc. Magazine Eric Edwards, co-founder and CEO of Phlow. Photo: Courtesy company. Illustration: Inc. Magazine ...
Richmond-based drug manufacturing company Phlow Corp., which incorporated this year, announced Tuesday that the Trump administration has awarded it a $354 million, four-year contract to manufacture in ...